Simon Rule

2.0k total citations
7 papers, 52 citations indexed

About

Simon Rule is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Simon Rule has authored 7 papers receiving a total of 52 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Genetics and 3 papers in Oncology. Recurrent topics in Simon Rule's work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lung Cancer Treatments and Mutations (2 papers). Simon Rule is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lung Cancer Treatments and Mutations (2 papers). Simon Rule collaborates with scholars based in United Kingdom, Australia and United States. Simon Rule's co-authors include Stephen A. Johnson, Stephen J. Davies, John E. Sanderson, Paul Brooksby, Andrew G. Nicholson, J. Tomlinson, Denise Howe, M. J. Phillips, Teresa Bromidge and Safaa Ramadan and has published in prestigious journals such as Blood, Postgraduate Medical Journal and Clinical Oncology.

In The Last Decade

Simon Rule

7 papers receiving 49 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Rule United Kingdom 4 33 27 18 12 11 7 52
G.K. Bascom United States 2 41 1.2× 27 1.0× 16 0.9× 8 0.7× 7 0.6× 2 63
Jason T. Romancik United States 5 33 1.0× 44 1.6× 13 0.7× 17 1.4× 3 0.3× 17 64
Lukas Kazianka Austria 4 28 0.8× 24 0.9× 5 0.3× 14 1.2× 7 0.6× 10 55
Pegah Farrokhi Iran 4 40 1.2× 22 0.8× 27 1.5× 17 1.4× 9 0.8× 6 63
Amanda Gillespie-Twardy United States 4 23 0.7× 23 0.9× 18 1.0× 8 0.7× 5 0.5× 8 45
Valentina Ivanova Russia 4 33 1.0× 21 0.8× 30 1.7× 5 0.4× 7 0.6× 9 43
Gavin Preston United Kingdom 5 36 1.1× 17 0.6× 28 1.6× 8 0.7× 26 2.4× 10 72
László Imre Pinczés Hungary 5 32 1.0× 26 1.0× 13 0.7× 11 0.9× 27 2.5× 23 70
Sandra Le Guyader-Peyrou France 3 56 1.7× 40 1.5× 33 1.8× 11 0.9× 10 0.9× 6 78
Elena Holm Sweden 4 25 0.8× 13 0.5× 8 0.4× 9 0.8× 9 0.8× 4 68

Countries citing papers authored by Simon Rule

Since Specialization
Citations

This map shows the geographic impact of Simon Rule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Rule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Rule more than expected).

Fields of papers citing papers by Simon Rule

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Rule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Rule. The network helps show where Simon Rule may publish in the future.

Co-authorship network of co-authors of Simon Rule

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Rule. A scholar is included among the top collaborators of Simon Rule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Rule. Simon Rule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Dreyling, Martin, Jiřı́ Mayer, David Belada, et al.. (2024). High-Risk Subgroups and MRD: An Updated Analysis of the Phase 3 ECHO Trial of Acalabrutinib with Bendamustine/Rituximab in Previously Untreated Mantle Cell Lymphoma. Blood. 144(Supplement 1). 1626–1626. 2 indexed citations
2.
Tam, Constantine S., Simon Rule, Steven Le Gouill, et al.. (2017). PHASE 3 STUDY OF IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (MCL). Hematological Oncology. 35(S2). 421–422. 2 indexed citations
3.
Peggs, K, Gary Cook, NH Russell, et al.. (2016). Reduced intensity conditioned allogeneic stem cell transplantation (RIC-Allo) as front-line therapy for mantle cell lymphoma (MCL): Results from the UK Phase II Mini Allo Study (CRUK: C7627/A9080). UCL Discovery (University College London). 2 indexed citations
4.
Tomlinson, J., et al.. (1999). Interstitial Pneumonitis Following Mitozantrone, Chlorambucil and Prednisolone (MCP) Chemotherapy. Clinical Oncology. 11(3). 184–186. 7 indexed citations
5.
Rule, Simon, et al.. (1998). Vinorelbine in the treatment of lymphoma. Hematological Oncology. 16(3). 101–105. 26 indexed citations
6.
Howe, Denise, et al.. (1997). Trisomy 12 is a Rare Event in Cases of CLL with Typical Immunophenotype and Morphology. Hematology. 2(5). 373–378. 6 indexed citations
7.
Rule, Simon, Paul Brooksby, & John E. Sanderson. (1993). Use of thrombolysis for acute myocardial infarction by general practitioners. Postgraduate Medical Journal. 69(809). 190–193. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026